EAM

EULAV Asset Management’s Biogen BIIB Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-37,015	Closed	-$10.5M	–	229
2021 Q3	$10.5M	Buy	37,015 +15	+0%	+$4.25K	0.28%	102
2021 Q2	$12.8M	Buy	+37,000	New	+$12.8M	0.34%	93
2020 Q1	–	Sell	-25,000	Closed	-$7.42M	–	258
2019 Q4	$7.42M	Buy	+25,000	New	+$7.42M	0.26%	104
2019 Q1	–	Sell	-32,000	Closed	-$9.63M	–	306
2018 Q4	$9.63M	Sell	32,000 -6,000	-16%	-$1.81M	0.48%	68
2018 Q3	$13.4M	Buy	38,000 +8,000	+27%	+$2.83M	0.58%	61
2018 Q2	$8.71M	Sell	30,000 -3,000	-9%	-$871K	0.4%	85
2018 Q1	$9.04M	Sell	33,000 -6,000	-15%	-$1.64M	0.43%	76
2017 Q4	$12.4M	Buy	39,000 +7,500	+24%	+$2.39M	0.59%	51
2017 Q3	$9.86M	Sell	31,500 -500	-2%	-$157K	0.47%	72
2017 Q2	$8.68M	Sell	32,000 -4,000	-11%	-$1.09M	0.43%	75
2017 Q1	$9.84M	Sell	36,000 -2,000	-5%	-$547K	0.5%	64
2016 Q4	$10.8M	Buy	38,000 +8,000	+27%	+$2.27M	0.58%	58
2016 Q3	$9.39M	Sell	30,000 -4,500	-13%	-$1.41M	0.5%	75
2016 Q2	$8.34M	Sell	34,500 -500	-1%	-$121K	0.46%	78
2016 Q1	$9.11M	Sell	35,000 -6,000	-15%	-$1.56M	0.51%	71
2015 Q4	$12.6M	Sell	41,000 -1,000	-2%	-$306K	0.69%	47
2015 Q3	$12.3M	Buy	42,000 +5,000	+14%	+$1.46M	0.7%	43
2015 Q2	$14.9M	Buy	37,000 +5,000	+16%	+$2.02M	0.78%	29
2015 Q1	$13.5M	Hold	32,000	–	–	0.7%	37
2014 Q4	$10.9M	Buy	32,000 +15,000	+88%	+$5.09M	0.58%	58
2014 Q3	$5.62M	Buy	17,000 +5,000	+42%	+$1.65M	0.31%	128
2014 Q2	$3.78M	Buy	12,000 +2,000	+20%	+$631K	0.2%	161
2014 Q1	$3.06M	Hold	10,000	–	–	0.17%	188
2013 Q4	$2.8M	Hold	10,000	–	–	0.15%	199
2013 Q3	$2.41M	Sell	10,000 -1,500	-13%	-$361K	0.14%	216
2013 Q2	$2.48M	Buy	+11,500	New	+$2.48M	0.15%	216